English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  52209739    Online Users :  1279
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"lin zu yau"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 1-23 of 23  (1 Page(s) Totally)
1 
View [10|25|50] records per page

Institution Date Title Author
嘉南藥理大學 2021 Eradication of hepatitis C virus preserve liver function and prolong survival in advanced hepatocellular carcinoma patients with limited life expectancy Yeh, Ming-Lun; Kuo, Hsing-Tao; Huang, Ching-, I; Huang, Chung-Feng; Hsieh, Ming-Yen; Liang, Po-Cheng; Lin, I-Hung; Hsieh, Meng-Hsuan; Lin, Zu-Yau; Chen, Shinn-Chern; Dai, Chia-Yen; Huang, Jee-Fu; Yu, Ming-Lung; Chuang, Wan-Long
國立交通大學 2020-10-05T02:02:03Z Hepatitis B-related outcomes following direct-acting antiviral therapy in Taiwanese patients with chronic HBV/HCV co-infection Liang, Po-Cheng; Tsai, Pei-Chien; Hsieh, Ming-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Huang, Jee-Fu; Dai, Chia-Yen; Chuang, Wan-Long; Chung, Raymond T.; Yu, Ming-Lung; Tsai, Yi-Shan; Hsieh, Meng-Hsuan; Yeh, Ming-Lun; Huang, Chung-Feng; Huang, Ching-, I; Holmes, Jacinta A.
國立交通大學 2020-10-05T01:59:45Z Cure or curd: Modification of lipid profiles and cardio-cerebrovascular events after hepatitis C virus eradication Huang, Chung-Feng; Dai, Chia-Yen; Yeh, Ming-Lun; Huang, Ching-, I; Lee, Hsiang-Chun; Lai, Wen-Ter; Liang, Po-Cheng; Lin, Yi-Hung; Hsieh, Ming-Yen; Hou, Nai-Jen; Lin, Zu-Yau; Chen, Shinn-Cherng; Huang, Jee-Fu; Chuang, Wan-Long; Yu, Ming-Lung
國立交通大學 2020-07-01 Clusters of Circulating let-7 Family Tumor Suppressors Are Associated with Clinical Characteristics of Chronic Hepatitis C Yu, Ming-Lung; Dai, Chia-Yen; Chuang, Wan-Long; Tsai, Yi-Shan; Yeh, Ming-Lun; Tsai, Pei-Chien; Huang, Ching-, I; Huang, Chung-Feng; Hsieh, Meng-Hsuan; Liu, Ta-Wei; Lin, Yi-Hung; Liang, Po-Cheng; Lin, Zu-Yau; Chen, Shinn-Cherng; Huang, Jee-Fu
國立交通大學 2020-05-05T00:02:21Z Serial serologic changes of hepatitis D virus in chronic hepatitis B patients receiving nucleos(t)ides analogues therapy Yu, Ming-Lung; Dai, Chia-Yen; Huang, Chung-Feng; Chuang, Wan-Long; Huang, Jee-Fu; Chen, Shinn-Cherng; Lin, Zu-Yau; Huang, Ching-, I; Yeh, Ming-Lun; Wang, Shu-Chi; Lin, Yi-Hung; Liang, Po-Cheng; Hsieh, Meng-Hsuan; Ko, Yu-Min; Tsai, Yi-Shan; Chen, Kuan-Yu; Lin, Ching-Chih; Tsai, Pei-Chien; Liu, Ta-Wei; Hsu, Po-Yao; Hsu, Cheng-Ting; Jang, Tyng-Yuan; Wei, Yu-Ju
國立交通大學 2019-12-13T01:09:55Z Improvement of hyperuricemia in chronic hepatitis C patients receiving directly acting antiviral agents Jang, Tyng-Yuan; Huang, Ching-, I; Yeh, Ming-Lun; Liang, Po-Cheng; Tsai, Pei-Chien; Lin, Yi-Hung; Hsieh, Ming-Yen; Hou, Nai-Jen; Lin, Zu-Yau; Chen, Shinn-Cherng; Huang, Jee-Fu; Dai, Chia-Yen; Huang, Chung-Feng; Chuang, Wan-Long; Yu, Ming-Lung
國立交通大學 2019-12-13T01:09:55Z Ribavirin facilitates early viral kinetics in chronic hepatitis C patients receiving daclatasvir/asunaprevir Huang, Chung-Feng; Yeh, Ming-Lun; Huang, Ching-, I; Liang, Po-Cheng; Lin, Yi-Hun; Hsieh, Ming-Yen; Chen, Kuan-Yu; Ko, Yu-Min; Lin, Zu-Yau; Chen, Shinn-Cherng; Huang, Jee-Fu; Dai, Chia-Yen; Chuang, Wan-Long; Yu, Ming-Lung
國立交通大學 2019-08-02T02:18:36Z Elevated interleukin-4 levels predicted advanced fibrosis in chronic hepatitis C Batsaikhan, Batbold; Lu, Ming-Ying; Yeh, Ming-Lun; Huang, Ching-, I; Huang, Chung-Feng; Lin, Zu-Yau; Chen, Shinn-Cherng; Huang, Jee-Fu; Hsieh, Ping-Hsin; Chuang, Wan-Long; Lee, Jin-Ching; Yu, Ming-Lung; Dai, Chia-Yen
國立交通大學 2019-08-02T02:18:29Z Equal treatment efficacy of direct-acting antivirals in patients with chronic hepatitis C and hepatocellular carcinoma? A prospective cohort study Huang, Chung-Feng; Yeh, Ming-Lun; Huang, Ching-I; Liang, Po-Cheng; Lin, Yi-Hung; Hsieh, Ming-Yen; Wei, Yu-Ju; Lin, Zu-Yau; Chen, Shinn-Cherng; Huang, Jee-Fu; Dai, Chia-Yen; Chuang, Wan-Long; Yu, Ming-Lung
國立交通大學 2019-04-02T06:01:07Z Association of serial serum major histocompatibility complex class I chain-related A measurements with hepatocellular carcinoma in chronic hepatitis C patients after viral eradication Huang, Chung-Feng; Wang, Shu-Chi; Yeh, Ming-Lun; Huang, Ching-I; Tsai, Pei-Chien; Lin, Zu-Yau; Chen, Shinn-Cherng; Dai, Chia-Yen; Huang, Jee-Fu; Chuang, Wan-Long; Chen, Angela; Yu, Ming-Lung
國立交通大學 2019-04-02T06:00:31Z Tolloid-like 1 genetic variants determine fibrosis regression in chronic hepatitis C patients with curative antivirals Huang, Chung-Feng; Yeh, Ming-Lun; Huang, Ching-, I; Lin, Zu-Yau; Chen, Shinn-Cherng; Huang, Jee-Fu; Dai, Chia-Yen; Chuang, Wan-Long; Chen, Jyh-Jou; Yu, Ming-Lung
國立交通大學 2019-04-02T05:59:55Z Association of hyperuricemia with disease severity in chronic hepatitis C patients Jang, Tyng-Yuan; Yeh, Ming-Lun; Huang, Ching-, I; Lin, Zu-Yau; Chen, Shinn-Cherng; Hsieh, Meng-Hsuan; Dai, Chia-Yen; Huang, Jee-Fu; Huang, Chung-Feng; Chuang, Wan-Long; Yu, Ming-Lung
國立交通大學 2019-04-02T05:59:49Z Lower protein expression levels of MHC class I chain-related gene A in hepatocellular carcinoma are at high risk of recurrence after surgical resection Huang, Chung-Feng; Wang, Shu-Chi; Chang, Wen-Tsan; Yeh, Ming-Lun; Huang, Ching-I; Lin, Zu-Yau; Chen, Shinn-Cherng; Chuang, Wan-Long; Huang, Jee-Fu; Dai, Chia-Yen; Chen, Yao-Li; Yu, Ming-Lung
國立交通大學 2019-04-02T05:59:10Z Post-treatment fibrotic modifications overwhelm pretreatment liver fibrosis in predicting HCC in CHC patients with curative antivirals Huang, Chung-Feng; Yeh, Ming-Lun; Huang, Ching-I; Liang, Po-Cheng; Lin, Yi-Hung; Lin, Zu-Yau; Chen, Shinn-Cherng; Huang, Jee-Fu; Dai, Chia-Yen; Chuang, Wan-Long; Yu, Ming-Lung
臺大學術典藏 2018-09-10T09:49:32Z Profound week 4 interferon responsiveness is mandatory for hepatitis C genotype 1 patients with unfavorable IL-28B genotype Huang, Chung-Feng;Yu, Ming-Lung;Kao, Jia-Horng;Tseng, Tai-Chung;Yeh, Ming-Lun;Huang, Jee-Fu;Dai, Chia-Yen;Lin, Zu-Yau;Chen, Shinn-Cherng;Wang, Liang-Yen;Juo, Suh-Hang Hank;Chuang, Wan-Long;Liu, Chen-Hua; CHEN-HUA LIU; Huang, Chung-Feng; Yu, Ming-Lung; JIA-HORNG KAO; Kao, Jia-Horng; Kao, Jia-Horng; Tseng, Tai-Chung; Tseng, Tai-Chung; Yeh, Ming-Lun; Yeh, Ming-Lun; Huang, Jee-Fu; Dai, Chia-Yen; Lin, Zu-Yau; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Juo, Suh-Hang Hank; Chuang, Wan-Long; Chuang, Wan-Long; Liu, Chen-Hua; Liu, Chen-Hua
臺大學術典藏 2018-09-10T09:14:10Z Revisiting the stopping rule for hepatitis C genotype 1 patients treated with peginterferon plus ribavirin. Yu, Ming-Lung; Liu, Chen-Hua; Huang, Chung-Feng; Tseng, Tai-Chung; Huang, Jee-Fu; Dai, Chia-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Juo, Suh-Hang Hank; Chuang, Wan-Long; Kao, Jia-Horng; Re, Valli De; CHEN-HUA LIU; Yu, Ming-Lung; Liu, Chen-Hua; JIA-HORNG KAO; Liu, Chen-Hua; Huang, Chung-Feng; Tseng, Tai-Chung; Huang, Jee-Fu; Dai, Chia-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Chen, Shinn-Cherng; Wang, Liang-Yen; Juo, Suh-Hang Hank; Chuang, Wan-Long; Kao, Jia-Horng; Kao, Jia-Horng; RE, Valli DE
國立交通大學 2018-08-21T05:53:33Z Interference of hepatitis B virus dual infection in platelet count recovery in chronic hepatitis C patients with curative antiviral therapy Huang, Chung-Feng; Yeh, Ming-Lun; Huang, Ching-I; Lin, Zu-Yau; Chen, Shinn-Cherng; Dai, Chia-Yen; Huang, Jee-Fu; Chuang, Wan-Long; Yu, Ming-Lung
國立成功大學 2015-09-15 Targeting chemotherapy-induced PTX3 in tumor stroma to prevent the progression of drug-resistant cancers Chi, Jhih-Ying; Hsiao, Yu-Wei; Li, Chien-Feng; Lo, Yu-Chih; Lin, Zu-Yau; Hong, Jhen-Yi; Liu, Yang-Ming; Han, Xiu; Wang, Shao-Ming; Chen, Ben-Kuen; Tsai, Kelvin K.; Wang, Ju-Ming
國立臺灣大學 2013 Profound week 4 interferon responsiveness is mandatory for hepatitis C genotype 1 patients with unfavorable IL-28B genotype Huang, Chung-Feng; Yu, Ming-Lung; Kao, Jia-Horng; Tseng, Tai-Chung; Yeh, Ming-Lun; Huang, Jee-Fu; Dai, Chia-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Juo, Suh-Hang Hank; Chuang, Wan-Long; Liu, Chen-Hua; 劉振驊; 高嘉宏
嘉南藥理大學 2012-05 Erratum to:"Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirin"[J Hepatol 2012;56:34–40] Huang, Chung-Feng; Huan, Jee-Fu; Yang, Jeng-Fu; Hsieh, Ming-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Juo, Suh-Hang Hank; Chen, Ku-Chung; Chuang, Wan-Long; Kuo, Hsing-Tao; Dai, Chia-Yen; Yu, Ming-Lung
嘉南藥理大學 2012 Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirin Huang, Chung-Feng; Huang, Jee-Fu; Yang, Jeng-Fu; Hsieh, Ming-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Juo, Suh-Hang Hank; Chen, Ku-Chung; Chuang, Wan-Long; Kuo, Hsing-Tao; Dai, Chia-Yen; Yu, Ming-Lung
國立臺灣大學 2012 Revisiting the Stopping Rule for Hepatitis C Genotype 1 Patients Treated with Peginterferon Plus Ribavirin Yu, Ming-Lung; Liu, Chen-Hua; Huang, Chung-Feng; Tseng, Tai-Chung; Huang, Jee-Fu; Dai, Chia-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Juo, Suh-Hang Hank; Chuang, Wan-Long; Kao, Jia-Horng; 劉振驊; 高嘉宏
國立臺灣大學 2011 Long-Term Effect of Interferon Plus Ribavirin on Hepatitis B Surface Antigen Seroclearance in Patients Dually Infected with Hepatitis B and C Viruses 葉明倫; 洪肇宏; 劉俊人; 李全謨; 王景弘; 林子堯; 盧勝男; 胡琮輝; 余明隆; 高嘉宏; 莊萬龍; 陳培哲; 陳定信; YEH, MING-LUN; HUNG, CHAO-HUNG; LIU, CHUN-JEN; LEE, CHUAN-MO; WANG, JING-HOUNG; LIN, ZU-YAU; LU, SHENG-NAN; HU, TSUNG-HUI; YU, MING-LUNG; KAO, JIA-HORNG; CHUANG, WAN-LONG; CHEN, PEI-JER; CHEN, DING-SHINN

Showing items 1-23 of 23  (1 Page(s) Totally)
1 
View [10|25|50] records per page